Branislava Gemović

Dr. Branislava Gemović

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2016 in Genome Biology
Verified
Journal Article
Open access
PDF file
YJYuxiang Jiang
Yuxiang Jiang
TOTal Ronnen Oron
Tal Ronnen Oron
WCWyatt T. Clark
Wyatt T. Clark
ABAsma R. Bankapur
Asma R. Bankapur
DDDaniel D’aNdrea
Daniel D’aNdrea
PRPredrag Radivojac
Predrag Radivojac
A major bottleneck in our understanding of the molecular underpinnings of life is the assignment of function to proteins. While molecular experiments provide the most reliable annotation of proteins, their relatively low throughput and restricted purview have led to an increasing role for computational function prediction. However, assessing methods for protein function prediction and tracking progress in the field remain challenging. We conducted the second critical assessment of functional annotation (CAFA), a timed challenge to assess computational methods that automatically assign protein function. We evaluated 126 methods from 56 research groups for their ability to predict biological functions using Gene Ontology and gene-disease associations using Human Phenotype Ontology on a set of 3681 proteins from 18 species. CAFA2 featured expanded analysis compared with CAFA1, with regards to data set size, variety, and assessment metrics. To review progress in the field, the analysis compared the best methods from CAFA1 to those of CAFA2. The top-performing methods in CAFA2 outperformed those from CAFA1. This increased accuracy can be attributed to a combination of the growing number of experimental annotations and improved methods for function prediction. The assessment also revealed that the definition of top-performing algorithms is ontology specific, that different performance metrics can be used to probe the nature of accurate predictions, and the relative diversity of predictions in the biological process and human phenotype ontologies. While there was methodological improvement between CAFA1 and CAFA2, the interpretation of results and usefulness of individual methods remain context-dependent.

12 November 2015 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MSMilan Sencanski
Milan Sencanski
DRDraginja Radosevic
Draginja Radosevic
VPVladimir Perovic
Vladimir Perovic
BGBranislava Gemović
Branislava Gemović
MSMaja Stanojevic
Maja Stanojevic
SGSanja Glisic
Sanja Glisic
The influenza virus represents a permanent global health threat because it circulates not only within but also between numerous host populations, thereby frequently causing unexpected outbreaks in animals and humans with a generally unpredictable course of disease and epidemiology. Conventional influenza therapy is directed against the viral neuraminidase protein, which promotes virus release from infected cells, and the viral ion channel M2, which facilitates viral uncoating. However, these drugs, albeit effective, have a major drawback: their targets are of a highly variable sequence. As a consequence, the virus can readily acquire resistance by mutating the drug targets. Indeed, most seasonal A/H1N1 viruses and the 2009 H1N1 virus are resistant to M2 inhibitors, and a significant proportion of the seasonal A/H1N1 viruses are resistant to the neuraminidase inhibitor oseltamivir. Development of new effective drugs for treatment of disease during the regular influenza seasons and the possible influenza pandemic represents an important goal. The results presented here point out natural products as a promising source of low toxic and widely accessible drug candidates for treatment of the influenza disease. Natural products combined with new therapeutic targets and drug repurposing techniques, which accelerate development of new drugs, serve as an important platform for development of new influenza therapeutics.

7 September 2016 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
VPVladimir Perovic
Vladimir Perovic
NSNeven Sumonja
Neven Sumonja
BGBranislava Gemović
Branislava Gemović
ETEneda Toska
Eneda Toska
SRStefan G Roberts
Stefan G Roberts
VVveljko veljkovic
veljko veljkovic
The TRI_tool, a sequence-based web tool for prediction of protein interactions in the human transcriptional regulation, is intended for biomedical investigators who work on understanding the regulation of gene expression. It has an improved predictive performance due to the training on updated, human specific, experimentally validated datasets. The TRI_tool is designed to test up to 100 potential interactions with no time delay and to report both probabilities and binarized predictions. http://www.vin.bg.ac.rs/180/tools/tfpred.php. Supplementary data are available at Bioinformatics online.

1 January 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
TSTatjana Srdic-Rajic
Tatjana Srdic-Rajic
Katarina NikolicKatarina Nikolic
Katarina Nikolic
MCMilena Cavic
Milena Cavic
IDIvana Djokic
Ivana Djokic
BGBranislava Gemović
Branislava Gemović
VVveljko veljkovic
veljko veljkovic

19 September 2019 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
BGBranislava Gemović
Branislava Gemović
NSNeven Sumonja
Neven Sumonja
RDRadoslav Davidovic
Radoslav Davidovic
VPVladimir Perovic
Vladimir Perovic
VVveljko veljkovic
veljko veljkovic
Background: The significant number of protein-protein interactions (PPIs) discovered by harnessing concomitant advances in the fields of sequencing, crystallography, spectrometry and two-hybrid screening suggests astonishing prospects for remodelling drug discovery. The PPI space which includes up to 650 000 entities is a remarkable reservoir of potential therapeutic targets for every human disease. In order to allow modern drug discovery programs to leverage this, we should be able to discern complete PPI maps associated with a specific disorder and corresponding normal physiology. Objective: Here, we will review community available computational programs for predicting PPIs and web-based resources for storing experimentally annotated interactions. Methods: We compared the capacities of prediction tools: iLoops, Struck2Net, HOMCOS, COTH, PrePPI, InterPreTS and PRISM to predict recently discovered protein interactions. Results: We described sequence-based and structure-based PPI prediction tools and addressed their peculiarities. Additionally, since the usefulness of prediction algorithms critically depends on the quality and quantity of the experimental data they are built on; we extensively discussed community resources for protein interactions. We focused on the active and recently updated primary and secondary PPI databases, repositories specialized to the subject or species, as well as databases that include both experimental and predicted PPIs. Conclusion: PPI complexes are the basis of important physiological processes and therefore, possible targets for cell-penetrating ligands. Reliable computational PPI predictions can speed up new target discoveries through prioritization of therapeutically relevant protein–protein complexes for experimental studies.

1 February 2013 in Combinatorial Chemistry & High Throughput Screening
Verified
Journal Article
Closed access
PDF file
Katarina NikolicKatarina Nikolic
Katarina Nikolic
VVveljko veljkovic
veljko veljkovic
BGBranislava Gemović
Branislava Gemović
TSTatjana Srdic-Rajic
Tatjana Srdic-Rajic
DADanica Agbaba
Danica Agbaba
The group of imidazoline-1 receptors (I1-IR) agonists encompasses drugs are currently used in treatment of high blood pressure and hyperglycemia. The I1-IR protein structures have not been determined yet, but Nischarin protein that binds numerous imidazoline ligands inducing initiation of various cell-signaling cascades, including apoptosis, is identified as strong I1-IR candidate. In this study we examined apoptotic activity of rilmenidine (potent I1-IR agonist), moxonidine (moderate I1-IR agonist), and efaroxan (I1-IR partial agonist) on cancer cell line (K562) expressing Nischarin. The Nischarine domains mapping was performed by use of the Informational Spectrum Method (ISM). The 3DQuantitative Structure-Activity Relationship (3D-QSAR) and virtual docking studies of 29 I1-IR ligands (agonists, partial agonists, and antagonists) were carried out on I1-IR receptors binding affinities. The 3D-QSAR study defined 3Dpharmacophore models for I1-IR agonistic and I1-IR antagonistic activity and created regression model for prediction of I1-IR activity of novel compounds. The 3D-QSAR models were applied for design and evaluation of novel I1-IR agonists and I1-IR antagonists. The most promising I1-IR ligands with enhanced activities than parent compounds were proposed for synthesis. The results of 3D-QSAR, ISM, and virtual docking studies were in perfect agreement and allowed precise definition of binding mode of I1-IR agonists (Arg 758, Arg 866, Val 981, and Glu 1057) and significantly different binding modes of I1-IR antagonists or partial I1-IR agonists. The performed theoretical study provides reliable system for evaluation of I1-IR agonistic and I1-IR antagonistic activity of novel I1-IR ligands, as drug candidates with anticancer activities.